Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Dis Esophagus

Retrieve available abstracts of 317 articles:
HTML format



Single Articles


    July 2021
  1. ERICHSEN SB, Slater J, Kiil BJ, Petersen TI, et al
    Oncological results and morbidity following intended curative resection and free jejunal graft reconstruction of cervical esophageal cancer: a retrospective Danish consecutive cohort study.
    Dis Esophagus. 2021 Jul 21. pii: 6324874. doi: 10.1093.
    PubMed     Abstract available


  2. CHIDAMBARAM S, Markar SR
    Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2021 Jul 21. pii: 6324875. doi: 10.1093.
    PubMed     Abstract available


  3. DUNN JM, Reyhani A, Santaolalla A, Zylstra J, et al
    Transition from esophagectomy to endoscopic therapy for early esophageal cancer.
    Dis Esophagus. 2021 Jul 15. pii: 6321381. doi: 10.1093.
    PubMed     Abstract available


  4. MATSUI K, Kawakubo H, Mayanagi S, Matsuda S, et al
    Exploratory prospective study of the influence of radical esophagectomy on perioperative physical activity in patients with thoracic esophageal cancer.
    Dis Esophagus. 2021 Jul 12. pii: 6319123. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  5. SHIM YM, Yun J, Im YH, Lee G, et al
    The efficacy of adjuvant chemotherapy with capecitabine and cisplatin after surgery in locally advanced esophageal squamous cell carcinoma: a multicenter randomized phase III trial.
    Dis Esophagus. 2021 Jun 21. pii: 6307360. doi: 10.1093.
    PubMed     Abstract available


  6. VAN DE VEN SEM, de Graaf W, Bugter O, Spaander MCW, et al
    Screening for synchronous esophageal second primary tumors in patients with head and neck cancer.
    Dis Esophagus. 2021 Jun 1. pii: 6290913. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  7. CAO Y, Han D, Zhou X, Han Y, et al
    Effects of preoperative nutrition on postoperative outcomes in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2021 May 10. pii: 6272654. doi: 10.1093.
    PubMed     Abstract available


  8. KAMARAJAH SK, Markar SR, Singh P, Griffiths EA, et al
    Corrigendum to: The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons.
    Dis Esophagus. 2021 May 8. pii: 6272293. doi: 10.1093.
    PubMed    


    April 2021
  9. MUMMUDI N, Jiwnani S, Niyogi D, Srinivasan S, et al
    Salvage radiotherapy for postoperative locoregional failure in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2021 Apr 29. pii: 6257764. doi: 10.1093.
    PubMed     Abstract available


  10. HAGENS E, Tukanova K, Jamel S, van Berge Henegouwen M, et al
    Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2021 Apr 24. pii: 6248490. doi: 10.1093.
    PubMed     Abstract available


  11. TAKEDA FR, Sallum RAA, Ribeiro U Jr, Cecconello I, et al
    Laparoscopic transhiatal esophagectomy in esophageal cancer patients with high-risk post-operative complications.
    Dis Esophagus. 2021 Apr 19. pii: 6231772. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  12. KALFF MC, van Berge Henegouwen MI, Gisbertz SS
    Textbook outcome for esophageal cancer surgery: an international consensus-based update of a quality measure.
    Dis Esophagus. 2021 Mar 22. pii: 6178961. doi: 10.1093.
    PubMed     Abstract available


  13. SCHURING N, Matsuda S, Hagens ERC, Sano J, et al
    A proposal for uniformity in classification of lymph node stations in esophageal cancer.
    Dis Esophagus. 2021 Mar 17. pii: 6174327. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  14. MOONS J, Depypere L, Lerut T, van Achterberg T, et al
    Impact of the introduction of an enhanced recovery pathway in esophageal cancer surgery: a cohort study and propensity score matching analysis.
    Dis Esophagus. 2021 Feb 18. pii: 6141530. doi: 10.1093.
    PubMed     Abstract available


  15. RAFTERY NB, Murphy CF, Donlon NE, Heneghan H, et al
    Prospective study of surgical site infections post-open esophageal cancer surgery, and the impact of care bundles.
    Dis Esophagus. 2021 Feb 16. pii: 6137282. doi: 10.1093.
    PubMed     Abstract available


  16. BARBARO A, Eldredge TA, Shenfine J
    Diagnosing anastomotic leak post-esophagectomy: a systematic review.
    Dis Esophagus. 2021;34.
    PubMed     Abstract available


  17. LI XK, Xu Y, Zhou H, Cong ZZ, et al
    Does robot-assisted minimally invasive oesophagectomy have superiority over thoraco-laparoscopic minimally invasive oesophagectomy in lymph node dissection?
    Dis Esophagus. 2021;34.
    PubMed     Abstract available


  18. MADHAVAN A, Kamarajah SK, Navidi M, Wahed S, et al
    The impact of age on patients undergoing transthoracic esophagectomy for cancer.
    Dis Esophagus. 2021;34.
    PubMed     Abstract available


    January 2021
  19. DING CZ, Wang GL, Wang HT, Wang WG, et al
    Esophagectomy combined with off-pump coronary artery bypass grafting through left posterolateral incision is safe and feasible for esophageal cancer associated with coronary artery disease.
    Dis Esophagus. 2021 Jan 14. pii: 6095855. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  20. ALVARADO CE, Worrell SG, Bachman KC, Gray K, et al
    Surgery following neoadjuvant chemoradiation therapy in clinical N3 esophageal cancer results in improved survival: a propensity-matched analysis.
    Dis Esophagus. 2020 Dec 21. pii: 6042247. doi: 10.1093.
    PubMed     Abstract available


  21. MAYANAGI S, Ishikawa A, Matsui K, Matsuda S, et al
    Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer.
    Dis Esophagus. 2020 Dec 12. pii: 6031240. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  22. CHAO YK, Wen YW
    Cost-effectiveness analysis of thoracoscopic versus open esophagectomy for esophageal cancer: a population-based study.
    Dis Esophagus. 2020 Nov 30. pii: 6009335. doi: 10.1093.
    PubMed     Abstract available


  23. REBECCHI F, Arolfo S, Ugliono E, Morino M, et al
    Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot.
    Dis Esophagus. 2020 Nov 27. pii: 6007422. doi: 10.1093.
    PubMed     Abstract available


  24. CHARALABOPOULOS A, Davakis S, Syllaios A, Lorenzi B, et al
    Intrathoracic hand-sewn esophagogastric anastomosis in prone position during totally minimally invasive two-stage esophagectomy for esophageal cancer.
    Dis Esophagus. 2020 Nov 12. pii: 5974937. doi: 10.1093.
    PubMed     Abstract available


  25. XU Y, Li XK, Cong ZZ, Zhou H, et al
    Long-term outcomes of robotic-assisted versus thoraco-laparoscopic McKeown esophagectomy for esophageal cancer: a propensity score-matched study.
    Dis Esophagus. 2020 Nov 5. pii: 5956162. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  26. TAKATSU J, Higaki E, Hosoi T, Yoshida M, et al
    Clinical benefits of a swallowing intervention for esophageal cancer patients after esophagectomy.
    Dis Esophagus. 2020 Oct 29. pii: 5942925. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  27. SAEED SM, Naffouje S, Mehta R, Hoffe SE, et al
    Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
    Dis Esophagus. 2020 Sep 30. pii: 5913221. doi: 10.1093.
    PubMed     Abstract available


  28. KAWASHIMA K, Abe S, Koga M, Nonaka S, et al
    Optimal selection of endoscopic resection in patients with esophageal squamous cell carcinoma: endoscopic mucosal resection versus endoscopic submucosal dissection according to lesion size.
    Dis Esophagus. 2020 Sep 22. pii: 5909779. doi: 10.1093.
    PubMed     Abstract available


  29. ARGUDO N, Rodo-Pin A, Martinez-Llorens J, Marco E, et al
    Feasibility, tolerability, and effects of exercise-based prehabilitation after neoadjuvant therapy in esophagogastric cancer patients undergoing surgery: an interventional pilot study.
    Dis Esophagus. 2020 Sep 17. pii: 5906903. doi: 10.1093.
    PubMed     Abstract available


  30. SUGITA Y, Nakamura T, Sawada R, Takiguchi G, et al
    Safety and feasibility of minimally invasive esophagectomy for elderly esophageal cancer patients.
    Dis Esophagus. 2020 Sep 7. pii: 5902470. doi: 10.1093.
    PubMed     Abstract available


  31. WAHED S, Chmelo J, Navidi M, Hayes N, et al
    Delivering esophago-gastric cancer care during the COVID-19 pandemic in the United Kingdom: a surgical perspective.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  32. NAKAJO K, Yoda Y, Kadota T, Murano T, et al
    Radial incision and cutting for dilation before endoscopic submucosal dissection in patients with esophageal cancer on the distal side of severe benign esophageal strictures.
    Dis Esophagus. 2020 Sep 2. pii: 5900452. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  33. SCHIZAS D, Mylonas KS, Hasemaki N, Mpaili E, et al
    Esophageal cancer surgery in Greece during the era of the financial crisis.
    Dis Esophagus. 2020 Aug 6. pii: 5881832. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  34. MARKAR S, Santoni G, Maret-Ouda J, Lagergren J, et al
    Hospital volume of esophageal cancer surgery in relation to outcomes from primary anti-reflux surgery.
    Dis Esophagus. 2020 Jul 22. pii: 5874719. doi: 10.1093.
    PubMed     Abstract available


  35. UEDA T, Dohi O, Naito Y, Yoshida T, et al
    Diagnostic performance of magnifying blue laser imaging versus magnifying narrow-band imaging for identifying the depth of invasion of superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2020 Jul 21. pii: 5874034. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  36. DAVARZANI N, Hewitt LC, Hale MD, Melotte V, et al
    Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial.
    Dis Esophagus. 2020 Jun 27. pii: 5863449. doi: 10.1093.
    PubMed     Abstract available


  37. MURPHY CF, Fanning M, Raftery N, Elliott JA, et al
    Early experience with a nutrition and survivorship clinic in esophageal cancer.
    Dis Esophagus. 2020 Jun 22. pii: 5860595. doi: 10.1093.
    PubMed     Abstract available


  38. KAMARAJAH SK, Markar SR, Singh P, Griffiths EA, et al
    The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons.
    Dis Esophagus. 2020 Jun 5. pii: 5851505. doi: 10.1093.
    PubMed     Abstract available


  39. FABBI M, Hagens ERC, van Berge Henegouwen MI, Gisbertz SS, et al
    Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment.
    Dis Esophagus. 2020 Jun 1. pii: 5849135. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  40. CHANG C, Worrell SG
    Viruses and esophageal cancer.
    Dis Esophagus. 2020 May 28. pii: 5847897. doi: 10.1093.
    PubMed     Abstract available


  41. BARBIERI L, Talavera Urquijo E, Parise P, Nilsson M, et al
    Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency.
    Dis Esophagus. 2020;33.
    PubMed    


  42. XU W, Liu XB, Li SB, Yang ZH, et al
    Prediction of lymph node metastasis in superficial esophageal squamous cell carcinoma in Asia: a systematic review and meta-analysis.
    Dis Esophagus. 2020 May 13. pii: 5836484. doi: 10.1093.
    PubMed     Abstract available


  43. SONG Q, Shi F, Xiao S, Li Y, et al
    The integration of proportion and cell counts of stromal, not intratumoral, PD-1+ tumor-infiltrating lymphocytes has prognostic significance in esophageal squamous cell carcinoma.
    Dis Esophagus. 2020 May 12. pii: 5835915. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  44. FUJIYOSHI T, Tajika M, Tanaka T, Ishihara M, et al
    Corrigendum to: Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2020 Apr 30. pii: 5827112. doi: 10.1093.
    PubMed    


  45. WATANABE A, Taniguchi M, Kimura Y, Kikkawa T, et al
    Larynx-preserving hybrid surgery with endoscopic laryngopharyngeal surgery and open surgery for cervical esophageal cancer invading pharynx.
    Dis Esophagus. 2020 Apr 30. pii: 5827017. doi: 10.1093.
    PubMed     Abstract available


  46. KAUL V, Bittner K, Ullah A, Kothari S, et al
    Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  47. KONRADSSON M, van Berge Henegouwen MI, Bruns C, Chaudry MA, et al
    Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  48. THAM JC, Dovell G, Berrisford RG, Humphreys ML, et al
    Routine use of feeding jejunostomy in oesophageal cancer resections: results of a survey in England.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


    March 2020
  49. KAMARAJAH SK, Lin A, Tharmaraja T, Bharwada Y, et al
    Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  50. JEREMIASEN M, Linder G, Hedberg J, Lundell L, et al
    Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007-2016 from a national quality register.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  51. MITCHELL KG, Nelson DB, Corsini EM, Vaporciyan AA, et al
    Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  52. STRUYVENBERG MR, van der Sommen F, Swager AF, de Groof AJ, et al
    Improved Barrett's neoplasia detection using computer-assisted multiframe analysis of volumetric laser endomicroscopy.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  53. SONG KY, Henn AJ, Gravely AA, Mesa H, et al
    Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


    February 2020
  54. DIAZ A, Burns S, D'Souza D, Kneuertz P, et al
    Accessing surgical care for esophageal cancer: patient travel patterns to reach higher volume center.
    Dis Esophagus. 2020 Feb 25. pii: 5756098. doi: 10.1093.
    PubMed     Abstract available


  55. LIU CY, Hsu PK, Hsu HS, Wu YC, et al
    Prognostic impact of circumferential resection margin in esophageal cancer with or without neoadjuvant chemoradiotherapy.
    Dis Esophagus. 2020 Feb 17. pii: 5739288. doi: 10.1093.
    PubMed     Abstract available


  56. YAMASAKI M, Yamashita K, Saito T, Tanaka K, et al
    Tracheal resection and anterior mediastinal tracheostomy in the multidisciplinary treatment of esophageal cancer with tracheal invasion.
    Dis Esophagus. 2020 Feb 14. pii: 5735623. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  57. KAMARAJAH SK, Newton N, Navidi M, Wahed S, et al
    Long-term outcomes of clinical and pathological-staged T3 N3 esophageal cancer.
    Dis Esophagus. 2020 Jan 16. pii: 5707333. doi: 10.1093.
    PubMed     Abstract available


  58. MINGLIANG W, Zhangyan K, Fangfang F, Huizhen W, et al
    Perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy: the first meta-analysis of randomized clinical trials.
    Dis Esophagus. 2020 Jan 16. pii: 5707342. doi: 10.1093.
    PubMed     Abstract available


  59. AHMED O, Bolger JC, O'Neill B, Robb WB, et al
    Use of esophageal stents to relieve dysphagia during neoadjuvant therapy prior to esophageal resection: a systematic review.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  60. BUNDRED J, Hollis AC, Hodson J, Hallissey MT, et al
    Validation of the NUn score as a predictor of anastomotic leak and major complications after Esophagectomy.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  61. KOTERAZAWA Y, Oshikiri T, Hasegawa H, Yamamoto M, et al
    Routine placement of feeding jejunostomy tube during esophagectomy increases postoperative complications and does not improve postoperative malnutrition.
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  62. ZHAN C, Shi Y, Jiang W, Sun F, et al
    How many lymph nodes should be dissected in esophagectomy with or without neoadjuvant therapy to get accurate staging?
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  63. EVANS RPT, Singh P, Nepogodiev D, Bundred J, et al
    Study protocol for a multicenter prospective cohort study on esophagogastric anastomoses and anastomotic leak (the Oesophago-Gastric Anastomosis Audit/OGAA).
    Dis Esophagus. 2020;33.
    PubMed     Abstract available


  64. ZHENG X, Ma X, Deng HY, Zha P, et al
    Diabetes mellitus and survival of esophageal cancer patients after esophagectomy: a systematic review and meta-analysis.
    Dis Esophagus. 2020 Jan 13. pii: 5701630. doi: 10.1093.
    PubMed     Abstract available


  65. DENG HY, Jiang R
    It is time to consider incorporating sarcopenia assessment in the management of esophageal cancer.
    Dis Esophagus. 2020 Jan 7. pii: 5697377. doi: 10.1093.
    PubMed    


    December 2019
  66. MAO YS, Gao SG, Wang Q, Shi XT, et al
    Analysis of a registry database for esophageal cancer from high-volume centers in China.
    Dis Esophagus. 2019 Dec 20. pii: 5681793. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  67. BJERRING OS, Larsen MK, Fristrup CW, Lundell L, et al
    The role of home visits by a nurse to improve palliation in patients treated with self-expandable metallic stents due to incurable esophageal cancer.
    Dis Esophagus. 2019 Nov 18. pii: 5628033. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  68. YUN JK, Chong BK, Kim HJ, Lee IS, et al
    Comparative outcomes of robot-assisted minimally invasive versus open esophagectomy in patients with esophageal squamous cell carcinoma: a propensity score-weighted analysis.
    Dis Esophagus. 2019 Oct 30. pii: 5610078. doi: 10.1093.
    PubMed     Abstract available


  69. DELLAPORTAS D, Laliotis A, Zylstra J, Davies A, et al
    Clinical significance of pulmonary nodules in decision-making and management of patients diagnosed with esophageal cancer.
    Dis Esophagus. 2019 Oct 25. pii: 5606686. doi: 10.1093.
    PubMed     Abstract available


  70. ROSEIRA J, Mao de Ferro S, Moleiro J, Currais P, et al
    Utility of stent double palliation for esophageal cancer with airway involvement: the extremis of care.
    Dis Esophagus. 2019 Oct 16. pii: 5588491. doi: 10.1093.
    PubMed     Abstract available


  71. ESAKI M, Hayashi Y, Ikehara H, Ihara E, et al
    The effect of scissor-type versus non-scissor-type knives on the technical outcomes in endoscopic submucosal dissection for superficial esophageal cancer: a multi-center retrospective study.
    Dis Esophagus. 2019 Oct 16. pii: 5588494. doi: 10.1093.
    PubMed     Abstract available


  72. YANG Y, Zhang X, Li B, Hua R, et al
    Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.
    Dis Esophagus. 2019 Oct 11. pii: 5585597. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  73. JIANG W, Verma V, Haque W, Moreno AC, et al
    Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.
    Dis Esophagus. 2019 Aug 28. pii: 5555765. doi: 10.1093.
    PubMed     Abstract available


  74. HOELSCHER A
    ISDE presidential biography: J R Siewert.
    Dis Esophagus. 2019;32.
    PubMed    


  75. WIETHALER M, Slotta-Huspenina J, Brandtner A, Horstmann J, et al
    BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinoma.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  76. GENTILE D, Riva P, Da Roit A, Basato S, et al
    Gastric tube cancer after esophagectomy for cancer: a systematic review.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  77. SOROUSH A, Poneros JM, Lightdale CJ, Abrams JA, et al
    Shorter time to achieve endoscopic eradication is not associated with improved long-term outcomes in Barrett's esophagus.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  78. CALLAHAN ZM, Shi Z, Su B, Xu J, et al
    Genetic variants in Barrett's esophagus and esophageal adenocarcinoma: a literature review.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  79. YANG GQ, Mhaskar R, Rishi A, Naghavi AO, et al
    Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  80. KINGMA BF, Visser E, Marsman M, Ruurda JP, et al
    Epidural analgesia after minimally invasive esophagectomy: efficacy and complication profile.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  81. FUJIWARA H, Kanamori J, Nakajima Y, Kawano T, et al
    An anatomical hypothesis: a "concentric-structured model" for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


    July 2019
  82. MINE S, Watanabe M
    Reply to 'Is there really no difference of mediastinal lymph node metastasis pattern between esophageal adenocarcinoma and squamous cell carcinoma?'
    Dis Esophagus. 2019;32.
    PubMed    


  83. RAJENDRA S, Sharma P
    Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  84. BRINKMANN S, Chang DH, Kuhr K, Hoelscher AH, et al
    Stenosis of the celiac trunk is associated with anastomotic leak after Ivor-Lewis esophagectomy.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  85. ZHA P, Deng HY
    Is there really no difference of mediastinal lymph node metastasis pattern between esophageal adenocarcinoma and squamous cell carcinoma?
    Dis Esophagus. 2019;32.
    PubMed    


    June 2019
  86. TAGKALOS E, Goense L, Hoppe-Lotichius M, Ruurda JP, et al
    Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: a propensity-matched analysis.
    Dis Esophagus. 2019 Jun 17. pii: 5519687. doi: 10.1093.
    PubMed     Abstract available


  87. ZHANG R, Zou J, Li P, Li Q, et al
    Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort.
    Dis Esophagus. 2019 Jun 7. pii: 5512616. doi: 10.1093.
    PubMed     Abstract available


  88. ZHANG G, Li J
    Reply to the Editor: how to treat esophageal neuroendocrine carcinoma with proper stratification?
    Dis Esophagus. 2019;32.
    PubMed    


  89. DENG HY
    How to treat esophageal neuroendocrine carcinoma with proper stratification?
    Dis Esophagus. 2019;32.
    PubMed    


  90. HADZIJUSUFOVIC E, Tagkalos E, Neumann H, Babic B, et al
    Preoperative endoscopic pyloric balloon dilatation decreases the rate of delayed gastric emptying after Ivor-Lewis esophagectomy.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


    May 2019
  91. INOUE T, Ito S, Kanda M, Niwa Y, et al
    Preoperative six-minute walk distance as a predictor of postoperative complication in patients with esophageal cancer.
    Dis Esophagus. 2019 May 20. pii: 5492604. doi: 10.1093.
    PubMed     Abstract available


  92. SCHLOTTMANN F, Gaber C, Strassle PD, Herbella FAM, et al
    Disparities in esophageal cancer: less treatment, less surgical resection, and poorer survival in disadvantaged patients.
    Dis Esophagus. 2019 May 10. pii: 5487976. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  93. GRIMMINGER PP, Hadzijusufovic E, Babic B, van der Sluis PC, et al
    Innovative fully robotic 4-arm Ivor Lewis esophagectomy for esophageal cancer (RAMIE4).
    Dis Esophagus. 2019 Apr 12. pii: 5450338. doi: 10.1093.
    PubMed     Abstract available


  94. TANAKA T, Ueno M, Iizuka T, Hoteya S, et al
    Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Dis Esophagus. 2019 Apr 12. pii: 5450336. doi: 10.1093.
    PubMed     Abstract available


  95. SUGAWARA K, Mori K, Yagi K, Aikou S, et al
    Association of preoperative inflammation-based prognostic score with survival in patients undergoing salvage esophagectomy.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  96. ERICSON J, Lundell L, Klevebro F, Kamiya S, et al
    Long-term weight development after esophagectomy for cancer-comparison between open Ivor-Lewis and minimally invasive surgical approaches.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


    March 2019
  97. NELSON DB, Mitchell KG, Weston BR, Betancourt S, et al
    Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?
    Dis Esophagus. 2019 Mar 19. pii: 5393319. doi: 10.1093.
    PubMed     Abstract available


  98. QIN J, Zhu HD, Guo JH, Ni CF, et al
    Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis.
    Dis Esophagus. 2019 Mar 19. pii: 5393322. doi: 10.1093.
    PubMed     Abstract available


  99. OGUMA J, Ozawa S, Kazuno A, Yamamoto M, et al
    Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2019 Mar 18. pii: 5382620. doi: 10.1093.
    PubMed     Abstract available


  100. CAI XW, Zeng Y, Feng W, Liu MN, et al
    Randomized phase II trial comparing tumor bed alone with tumor bed and elective nodal postoperative radiotherapy in patients with locoregionally advanced thoracic esophageal squamous cell carcinoma.
    Dis Esophagus. 2019 Mar 11. pii: 5373138. doi: 10.1093.
    PubMed     Abstract available


  101. HELMINEN O, Kauppila JH, Kyto V, Gunn J, et al
    Preoperative esophageal stenting and short-term outcomes of surgery for esophageal cancer in a population-based study from Finland and Sweden.
    Dis Esophagus. 2019 Mar 11. pii: 5373135. doi: 10.1093.
    PubMed     Abstract available


  102. DENG HY, Zheng X, Zha P, Liang H, et al
    Can we perform esophagectomy for esophageal cancer patients with concomitant liver cirrhosis? A comprehensive systematic review and meta-analysis.
    Dis Esophagus. 2019 Mar 4. pii: 5369049. doi: 10.1093.
    PubMed     Abstract available


  103. ARHI CS, Markar S, Burns EM, Bouras G, et al
    Delays in referral from primary care are associated with a worse survival in patients with esophagogastric cancer.
    Dis Esophagus. 2019 Mar 1. pii: 5367737. doi: 10.1093.
    PubMed     Abstract available


  104. DENG HY, Hou L, Zha P
    Sarcopenia: an unneglectable nutritional status in oncological esophagectomy.
    Dis Esophagus. 2019;32.
    PubMed    


  105. STENSTRA MHBC, van Workum F, van den Wildenberg FJH, Polat F, et al
    Evolution of the surgical technique of minimally invasive Ivor-Lewis esophagectomy: description according to the IDEAL framework.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  106. SOMA D, Kawamura YI, Yamashita S, Wake H, et al
    Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


    February 2019
  107. MARKAR SR, Wiggins T, MacKenzie H, Faiz O, et al
    Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study.
    Dis Esophagus. 2019 Feb 27. pii: 5365771. doi: 10.1093.
    PubMed     Abstract available


  108. OGUMA J, Ozawa S, Kazuno A, Yamamoto M, et al
    Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2019 Feb 27. pii: 5365772. doi: 10.1093.
    PubMed     Abstract available


  109. MINE S, Watanabe M, Kumagai K, Okamura A, et al
    Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Dis Esophagus. 2019 Feb 22. pii: 5355647. doi: 10.1093.
    PubMed     Abstract available


  110. LI L, Linghu E, Chai N, Li Z, et al
    Efficacy of triamcinolone-soaked polyglycolic acid sheet plus fully covered metal stent for preventing stricture formation after large esophageal endoscopic submucosal dissection.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  111. WANG A, Tan Y, Geng X, Chen X, et al
    Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  112. VON DOBELN GA, Klevebro F, Jacobsen AB, Johannessen HO, et al
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  113. VAN WORKUM F, Rosman C
    Author's response regarding manuscript 'Evolution of the surgical technique of minimally invasive Ivor-Lewis esophagectomy: description according to the IDEAL framework'.
    Dis Esophagus. 2019;32.
    PubMed    


    January 2019
  114. DUITS LC, Lao-Sirieix P, Wolf WA, O'Donovan M, et al
    A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


  115. DENG HY, Alai G, Li G, Luo J, et al
    High BMI has no impact on the survival of Chinese patients with lower thoracic esophageal adenocarcinoma treated with curative esophagectomy: a propensity score-matched study.
    Dis Esophagus. 2019;32.
    PubMed     Abstract available


    December 2018
  116. BAKHOS CT, Salami AC, Kaiser LR, Petrov RV, et al
    Outcomes of octogenarians with esophageal cancer: an analysis of the National Cancer Database.
    Dis Esophagus. 2018 Dec 31. pii: 5267099. doi: 10.1093.
    PubMed     Abstract available


  117. A VON DOBELN G, Klevebro F, Nilsson M
    Reply to letter: Neoadjuvant chemoradiotherapy or chemotherapy for esophageal cancer: what is the current evidence?
    Dis Esophagus. 2018 Dec 17. pii: 5250780. doi: 10.1093.
    PubMed    


  118. HOVERSTEN P, Kamboj AK, Katzka DA
    Infections of the esophagus: an update on risk factors, diagnosis, and management.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  119. WONG MYW, Wang B, Yang A, Khor A, et al
    Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  120. KUMAGAI Y, Hatano S, Sobajima J, Ishiguro T, et al
    Indocyanine green fluorescence angiography of the reconstructed gastric tube during esophagectomy: efficacy of the 90-second rule.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  121. ZHANG Y, Xiang J, Han Y, Huang M, et al
    Initial experience of robot-assisted Ivor-Lewis esophagectomy: 61 consecutive cases from a single Chinese institution.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    November 2018
  122. KLEVEBRO F, Johar A, Lagergren J, Lagergren P, et al
    Outcomes of nutritional jejunostomy in the curative treatment of esophageal cancer.
    Dis Esophagus. 2018 Nov 28. pii: 5212877. doi: 10.1093.
    PubMed     Abstract available


  123. DENG HY, Zha P, Peng L, Hou L, et al
    Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.
    Dis Esophagus. 2018 Nov 28. pii: 5212879. doi: 10.1093.
    PubMed     Abstract available


  124. DENG HY, Luo J, Li SX, Li G, et al
    Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-t
    Dis Esophagus. 2018 Nov 28. pii: 5212882. doi: 10.1093.
    PubMed     Abstract available


  125. NOBEL TB, Lavery JA, Barbetta A, Gennarelli RL, et al
    National guidelines may reduce socioeconomic disparities in treatment selection for esophageal cancer.
    Dis Esophagus. 2018 Nov 28. pii: 5212884. doi: 10.1093.
    PubMed     Abstract available


  126. WU PI, Szczesniak MM, Maclean J, Graham PH, et al
    Endoscopic dilatation improves long-term dysphagia following head and neck cancer therapies: a randomized control trial.
    Dis Esophagus. 2018 Nov 20. pii: 5193472. doi: 10.1093.
    PubMed     Abstract available


  127. SAWAS T, Visrodia KH, Zakko L, Lutzke LS, et al
    Clutch cutter is a safe device for performing endoscopic submucosal dissection of superficial esophageal neoplasms: a western experience.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  128. ELURI S, Klaver E, Duits LC, Jackson SA, et al
    Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  129. SEESING MFJ, Scheijmans JCG, Borggreve AS, van Hillegersberg R, et al
    The predictive value of new-onset atrial fibrillation on postoperative morbidity after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    October 2018
  130. DENG HY, Hou L, Huang KL
    Neoadjuvant chemoradiotherapy or chemotherapy for esophageal cancer: what is the current evidence?
    Dis Esophagus. 2018 Oct 30. pii: 5149491. doi: 10.1093.
    PubMed    


  131. ZHANG YH, Herlin G, Rouvelas I, Nilsson M, et al
    Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response.
    Dis Esophagus. 2018 Oct 8. pii: 5123416. doi: 10.1093.
    PubMed     Abstract available


  132. ZHANG R, Jia M, Li P, Han J, et al
    Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database.
    Dis Esophagus. 2018 Oct 1. pii: 5114250. doi: 10.1093.
    PubMed     Abstract available


  133. KLEVEBRO F, Scandavini CM, Kamiya S, Nilsson M, et al
    Single center consecutive series cohort study of minimally invasive versus open resection for cancer in the esophagus or gastroesophageal junction.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  134. BOSHIER PR, Adam ME, Doran S, Muthuswamy K, et al
    Effects of intraoperative pyloric stretch procedure on outcomes after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    September 2018
  135. CHEN YH, Yeh CJ, Wen YW, Chuang WY, et al
    Do dysplastic proximal resection margins predict the risk of anastomotic recurrence and overall survival in patients with esophageal squamous cell carcinoma?
    Dis Esophagus. 2018 Sep 17. pii: 5098583. doi: 10.1093.
    PubMed     Abstract available


  136. GOENSE L, Meziani J, Bulbul M, Braithwaite SA, et al
    Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer.
    Dis Esophagus. 2018 Sep 17. pii: 5098586. doi: 10.1093.
    PubMed     Abstract available


  137. ZHANG R, Li Y, Liu S, Liu X, et al
    FA01.03: USE OF 'NON-TUBE NO FASTING' ERAS PROTOCOL IN PATIENTS AFTER MIE WITH LI'S ANASTOMOSIS: OUTCOMES IN THE FIRST 113 PATIENTS PERFORMED BY A SURGEON AFTER TRAINING COURSE.
    Dis Esophagus. 2018;31:1-2.
    PubMed     Abstract available


  138. FRANSEN L, Berkelmans G, Asti E, Van Berge Henegouwen M, et al
    FA01.02: THE EFFECT OF POSTOPERATIVE COMPLICATIONS AFTER MIE ON LONG-TERM SURVIVAL: A RETROSPECTIVE, MULTI-CENTER COHORT STUDY.
    Dis Esophagus. 2018;31:1.
    PubMed     Abstract available


  139. KWAN KIT CHAN D, Siu Yin Chan F, King Hung Tong D, Yu Hong Wong I, et al
    FA01.01: MINIMALLY INVASIVE APPROACH RESULTS IN BETTER OUTCOME COMPARED TO OPEN ESOPHAGECTOMY-A PROPENSITY SCORE MATCHED ANALYSIS.
    Dis Esophagus. 2018;31:1.
    PubMed     Abstract available


  140. YOSHIDA N, Baba Y, Kuroda D, Miyamoto Y, et al
    Clinical utility of exhaled carbon monoxide in assessing preoperative smoking status and risks of postoperative morbidity after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  141. ENG OS, Nelson RA, Konstantinidis I, Chao J, et al
    Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    August 2018
  142. RUBENSTEIN JH, Morgenstern H, Longstreth K
    Clustering of esophageal cancer among white men in the United States.
    Dis Esophagus. 2018 Aug 30. pii: 5087691. doi: 10.1093.
    PubMed     Abstract available


  143. OHKURA Y, Ueno M, Shindoh J, Iizuka T, et al
    Randomized controlled trial on efficacy of oligomeric formula (HINE E-GEL(R)) versus polymeric formula (MEIN(R)) enteral nutrition after esophagectomy for esophageal cancer with gastric tube reconstruction.
    Dis Esophagus. 2018 Aug 29. pii: 5086657. doi: 10.1093.
    PubMed     Abstract available


  144. TIAN D, Zhang L, Wang Y, Chen L, et al
    Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.
    Dis Esophagus. 2018 Aug 27. pii: 5084843. doi: 10.1093.
    PubMed     Abstract available


  145. GRAHAM-WISENER L, Collins L, Hanna J, Dempster M, et al
    The need for enhanced psychological support in esophageal cancer-an exploratory study of the perception of HCPs, patients, and carers.
    Dis Esophagus. 2018 Aug 16. pii: 5075410. doi: 10.1093.
    PubMed     Abstract available


  146. KONNO-KUMAGAI T, Fujishima F, Nakamura Y, Nakano T, et al
    Programmed death-1 ligands and tumor infiltrating T lymphocytes in primary and lymph node metastasis of esophageal cancer patients.
    Dis Esophagus. 2018 Aug 6. pii: 5066745. doi: 10.1093.
    PubMed     Abstract available


  147. YUEN MTY, Tsang RK, Wong IYH, Chan DKK, et al
    Long-term pharyngeal dysphagia after esophagectomy for esophageal cancer-an investigation using videofluoroscopic swallow studies.
    Dis Esophagus. 2018 Aug 2. pii: 5063837. doi: 10.1093.
    PubMed     Abstract available


  148. CHEN SB, Huang SJ, Liu DT, Weng HR, et al
    Clinicopathological features and prognosis of esophageal squamous cell carcinoma in young patients.
    Dis Esophagus. 2018 Aug 1. pii: 5063602. doi: 10.1093.
    PubMed     Abstract available


  149. SUNDE B, Johnsen G, Jacobsen AB, Glenjen NI, et al
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial.
    Dis Esophagus. 2018 Aug 1. pii: 5063601. doi: 10.1093.
    PubMed     Abstract available


  150. KANEOKA A, Yang S, Inokuchi H, Ueha R, et al
    Presentation of oropharyngeal dysphagia and rehabilitative intervention following esophagectomy: a systematic review.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    July 2018
  151. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
    Dis Esophagus. 2018 Jul 23. pii: 5057168. doi: 10.1093.
    PubMed     Abstract available


  152. CHENG B, Yu J
    Predictive value of diffusion-weighted MR imaging in early response to chemoradiotherapy of esophageal cancer: a meta-analysis.
    Dis Esophagus. 2018 Jul 16. pii: 5054272. doi: 10.1093.
    PubMed     Abstract available


  153. AADAM AA, Abe S
    Endoscopic submucosal dissection for superficial esophageal cancer.
    Dis Esophagus. 2018 Jul 5. pii: 5049297. doi: 10.1093.
    PubMed     Abstract available


  154. MEREDITH K, Huston J, Andacoglu O, Shridhar R, et al
    Safety and feasibility of robotic-assisted Ivor-Lewis esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  155. IIZUKA T, Kikuchi D, Hoteya S, Kaise M, et al
    Effectiveness of modified oral steroid administration for preventing esophageal stricture after entire circumferential endoscopic submucosal dissection.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    June 2018
  156. CHEN J, Lin Y, Cai W, Su T, et al
    A new clinical staging system for esophageal cancer to predict survival after definitive chemoradiation or radiotherapy.
    Dis Esophagus. 2018 Jun 29. pii: 5046764. doi: 10.1093.
    PubMed     Abstract available


  157. COSGROVE ND, Mullady DK
    Endoscopic evaluation of the esophageal cancer patient after chemoradiotherapy for persistent/recurrent cancer.
    Dis Esophagus. 2018 Jun 19. pii: 5040371. doi: 10.1093.
    PubMed     Abstract available


  158. KROESE TE, Goense L, van Hillegersberg R, de Keizer B, et al
    Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Dis Esophagus. 2018 Jun 16. pii: 5039611. doi: 10.1093.
    PubMed     Abstract available


  159. DOHERTY MK, Leung Y, Su J, Naik H, et al
    Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.
    Dis Esophagus. 2018 Jun 14. pii: 5037798. doi: 10.1093.
    PubMed     Abstract available


  160. SUN S, Chen P, Meng L, Li L, et al
    High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
    Dis Esophagus. 2018 Jun 14. pii: 5037792. doi: 10.1093.
    PubMed     Abstract available


  161. SAITO Y, Takeuchi H, Fukuda K, Suda K, et al
    Size of recurrent laryngeal nerve as a new risk factor for postoperative vocal cord paralysis.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  162. SEESING MFJ, Wirsching A, van Rossum PSN, Weijs TJ, et al
    Defining pneumonia after esophagectomy for cancer: validation of the Uniform Pneumonia Score in a high volume center in North America.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  163. MENGARDO V, Pucetti F, Mc Cormack O, Chaudry A, et al
    The impact of obesity on esophagectomy: a meta-analysis.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    May 2018
  164. CHEN MJ, Wu IC, Chen YJ, Wang TE, et al
    Nutrition therapy in esophageal cancer-Consensus statement of the Gastroenterological Society of Taiwan.
    Dis Esophagus. 2018 May 31. pii: 5025886. doi: 10.1093.
    PubMed     Abstract available


  165. BOSHIER PR, Heneghan R, Markar SR, Baracos VE, et al
    Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2018 May 26. pii: 5006250. doi: 10.1093.
    PubMed     Abstract available


  166. KUMAGAI Y, Tachikawa T, Higashi M, Sobajima J, et al
    Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
    Dis Esophagus. 2018 May 23. pii: 5001991. doi: 10.1093.
    PubMed     Abstract available


  167. FELTRACCO P, Bortolato A, Barbieri S, Michieletto E, et al
    Perioperative benefit and outcome of thoracic epidural in esophageal surgery: a clinical review.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    April 2018
  168. PARK SY, Kim DJ, Kang DR, Haam SJ, et al
    Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer.
    Dis Esophagus. 2018 Apr 13. pii: 4969978. doi: 10.1093.
    PubMed    


  169. MIZUMOTO T, Hiyama T, Oka S, Yorita N, et al
    Diagnosis of superficial esophageal squamous cell carcinoma invasion depth before endoscopic submucosal dissection.
    Dis Esophagus. 2018;31.
    PubMed    


  170. HARRISON M, Allen JE, Gorrepati VS, Lopez-Jamar JME, et al
    Management of Barrett's esophagus with low-grade dysplasia.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  171. BELMOUHAND M, Svendsen LB, Kofoed SC, Normann G, et al
    Recurrence following curative intended surgery for an adenocarcinoma in the gastroesophageal junction: a retrospective study.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  172. KUMABE A, Fukada J, Kota R, Koike N, et al
    Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  173. KAHN A, Al-Qaisi M, Kommineni VT, Callaway JK, et al
    Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  174. STIER MW, Lodhia N, Jacobs J, Nozicka D, et al
    Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    March 2018
  175. SARVEPALLI S, Garg SK, Sarvepalli SS, Parikh MP, et al
    Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay.
    Dis Esophagus. 2018 Mar 28. pii: 4956135. doi: 10.1093.
    PubMed     Abstract available


  176. MC CORMACK O, Mengardo V, Pucetti F, Chaudry A, et al
    Reply to letter: obesity and esophagectomy for esophageal cancer: is it only the high BMI that defines prognosis?
    Dis Esophagus. 2018 Mar 28. pii: 4956134. doi: 10.1093.
    PubMed    


  177. NAKAHARA Y, Yamasaki M, Miyazaki Y, Tanaka K, et al
    Reflux after esophagectomy with gastric conduit reconstruction in the posterior mediastinum for esophageal cancer: original questionnaire and EORTC QLQ-C30 survey.
    Dis Esophagus. 2018 Mar 28. pii: 4956131. doi: 10.1093.
    PubMed     Abstract available


  178. DENG HY, Huang WX, Li G, Li SX, et al
    Comparison of short-term outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy in treating middle thoracic esophageal cancer.
    Dis Esophagus. 2018 Mar 9. pii: 4925701. doi: 10.1093.
    PubMed     Abstract available


  179. TSILIMIGRAS DI, Schizas D, Moris D, Liakakos T, et al
    Obesity and esophagectomy for esophageal cancer: is it only the high BMI that defines prognosis?
    Dis Esophagus. 2018 Mar 7. pii: 4924676. doi: 10.1093.
    PubMed    


  180. HARADA K, Yoshida N, Baba Y, Nakamura K, et al
    Pyloroplasty may reduce weight loss 1 year after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  181. MEGE D, Depypere L, Piessen G, Slaman AE, et al
    Surgical management of esophageal sarcoma: a multicenter European experience.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  182. GADDAM S
    Prediction of Barrett's esophagus: are we there yet?
    Dis Esophagus. 2018;31.
    PubMed    


  183. ELSHAER M, Gravante G, Tang CB, Jayanthi NV, et al
    Totally minimally invasive two-stage esophagectomy with intrathoracic hand-sewn anastomosis: short-term clinical and oncological outcomes.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  184. ORTIZ-FERNANDEZ-SORDO J, Sami SS, Mansilla-Vivar R, Subramanian V, et al
    Evaluation of a novel infra-red endoscopy system in the assessment of early neoplasia in Barretts esophagus: pilot study from a single center.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  185. SUBRAMANIAM S, Kandiah K, Chedgy F, Meredith P, et al
    The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


  186. DAVIES AR, Zylstra J, Baker CR, Gossage JA, et al
    A comparison of the left thoracoabdominal and Ivor-Lewis esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    February 2018
  187. KOSUMI K, Yoshida N, Okadome K, Eto T, et al
    Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer.
    Dis Esophagus. 2018 Feb 9. pii: 4850445. doi: 10.1093.
    PubMed     Abstract available


  188. LEE J, Chin JH, Kim JI, Lee EH, et al
    Association between red blood cell transfusion and long-term mortality in patients with cancer of the esophagus after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Abstract available


    January 2018
  189. FUJISHIMA F, Taniyama Y, Nakamura Y, Okamoto H, et al
    Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy.
    Dis Esophagus. 2018 Jan 13. pii: 4807355. doi: 10.1093.
    PubMed     Abstract available


  190. WINIKER M, Mantziari S, Figueiredo SG, Demartines N, et al
    Accuracy of preoperative staging for a priori resectable esophageal cancer.
    Dis Esophagus. 2018;31:1-6.
    PubMed     Abstract available


  191. FUCHS HF, Schmidt HM, Meissner M, Brinkmann S, et al
    Endoscopic and histopathologic reflux-associated mucosal damage in the remnant esophagus following transthoracic esophagectomy for cancer-5-year long-term follow-up.
    Dis Esophagus. 2018;31:1-6.
    PubMed     Abstract available


  192. BERKELMANS GHK, Fransen L, Weijs TJ, Lubbers M, et al
    The long-term effects of early oral feeding following minimal invasive esophagectomy.
    Dis Esophagus. 2018;31:1-8.
    PubMed     Abstract available


    December 2017
  193. MARKAR SR, Johar A, Maisey N, Lagergren P, et al
    Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.
    Dis Esophagus. 2017 Dec 22. pii: 4774516. doi: 10.1093.
    PubMed     Abstract available


  194. BUCKSTEIN M, Rhome R, Ru M, Moshier E, et al
    Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
    Dis Esophagus. 2017 Dec 22. pii: 4772688. doi: 10.1093.
    PubMed     Abstract available


  195. MINAMI T, Yuasa N, Miyake H, Takeuchi E, et al
    MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2017 Dec 19. pii: 4762060. doi: 10.1093.
    PubMed     Abstract available


  196. LI HX, Liu J, Cheng Y, Liu MN, et al
    Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.
    Dis Esophagus. 2017 Dec 19. pii: 4774512. doi: 10.1093.
    PubMed     Abstract available


  197. MIZUMOTO T, Hiyama T, Oka S, Yorita N, et al
    Diagnosis of superficial esophageal squamous cell carcinoma invasion depth before endoscopic submucosal dissection.
    Dis Esophagus. 2017 Dec 18. pii: 4757113. doi: 10.1093.
    PubMed     Abstract available


  198. BOSHIER PR, Ziff C, Adam ME, Fehervari M, et al
    Effect of perioperative blood transfusion on the long-term survival of patients undergoing esophagectomy for esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017 Dec 18. pii: 4757112. doi: 10.1093.
    PubMed     Abstract available


  199. KIM D, Min YW, Park JG, Lee H, et al
    Influence of esophagectomy on the gastroesophageal reflux in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  200. CHAO YK, Ku HY, Chen CY, Liu TW, et al
    Induction therapy before surgery improves survival in patients with clinical T3N0 esophageal cancer: a nationwide study in Taiwan.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  201. PARK SY, Kim DJ, Kang DR, Haam SJ, et al
    Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Abstract available


  202. KOSUMI K, Baba Y, Yamashita K, Ishimoto T, et al
    Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Abstract available


    November 2017
  203. MAKINO T, Yamasaki M, Miyazaki Y, Wada N, et al
    Utility of initial induction chemotherapy with 5-fluorouracil, cisplatin, and docetaxel (DCF) for T4 esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2017 Nov 28. pii: 4670862. doi: 10.1093.
    PubMed     Abstract available


  204. VISSER E, van Rossum PSN, van Veer H, Al-Naimi K, et al
    A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe.
    Dis Esophagus. 2017 Nov 7. doi: 10.1093.
    PubMed     Abstract available


  205. KIKUCHI D, Iizuka T, Hoteya S, Nomura K, et al
    Vascular density of superficial esophageal squamous cell carcinoma determined by direct observation of resected specimen using narrow band imaging with magnifying endoscopy.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  206. MODI RM, Mikhail S, Ciombor K, Perry KA, et al
    Outcomes of nutritional interventions to treat dysphagia in esophageal cancer: a population-based study.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  207. YAMASHITA K, Makino T, Yamasaki M, Tanaka K, et al
    Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  208. TSAI FC, Ghorbani S, Greenwald BD, Jang S, et al
    Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  209. TAKAHASHI K, Sato Y, Takeuchi M, Sato H, et al
    Changes in esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer: a high-resolution manometry study.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  210. KOHLI DR, Schubert ML, Zfass AM, Shah TU, et al
    Performance characteristics of optical coherence tomography in assessment of Barrett's esophagus and esophageal cancer: systematic review.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  211. FUJIYOSHI T, Tajika M, Tanaka T, Ishihara M, et al
    Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  212. CORAL RP, Constant-Neto M, Silva IS, Barros S, et al
    The influence of the transposed stomach through the posterior mediastinum on the respiratory forced expiratory volume and forced vital capacity in patients with resected esophageal cancer.
    Dis Esophagus. 2017;11:48-50.
    PubMed     Abstract available


    October 2017
  213. AL NATOUR RH, Catanzaro A, Zolotarevsky E, DeBenedet AT, et al
    Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Abstract available


  214. TIE H, He F, Shen J, Zhang B, et al
    Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Abstract available


  215. SUN SY, Zhao BQ, Wang J, Mo ZX, et al
    The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma.
    Dis Esophagus. 2017 Oct 25. doi: 10.1093.
    PubMed     Abstract available


  216. GRAHAM-WISENER L, Dempster M
    Peer advice giving from posttreatment to newly diagnosed esophageal cancer patients.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  217. OH TK, Jeon JH, Lee JM, Kim MS, et al
    Association of high-dose postoperative opioids with recurrence risk in esophageal squamous cell carcinoma: reinterpreting ERAS protocols for long-term oncologic surgery outcomes.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  218. BOHLE W, Kasper M, Zoller WG
    Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  219. CHEN CY, Hsieh VC, Chang CH, Chen PR, et al
    Impacts of treatments on the quality of life among esophageal squamous cell carcinoma patients.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  220. FUJIWARA H, Shiozaki A, Konishi H, Kosuga T, et al
    Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  221. DAI Z, Lang W, Yang H, Tian J, et al
    Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


    September 2017
  222. LI QW, Qiu B, Wang B, Wang DL, et al
    Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
    Dis Esophagus. 2017 Sep 27. doi: 10.1093.
    PubMed     Abstract available


  223. DEPYPERE L, Moons J, Lerut T, De Hertogh G, et al
    Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Dis Esophagus. 2017 Sep 27. doi: 10.1093.
    PubMed     Abstract available


  224. OKAMURA A, Watanabe M, Mine S, Kurogochi T, et al
    Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  225. SHEN S, Araujo JL, Altorki NK, Sonett JR, et al
    Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  226. WELCH G, Ross HJ, Patel NP, Jaroszewski DE, et al
    Incidence of brain metastasis from esophageal cancer.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


  227. TSANG JS, Tong DKH, Lam KO, Law BTT, et al
    Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  228. SONG T, Du D, Zhang X, Fang M, et al
    Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Abstract available


  229. MA Z, Chen C, Tang P, Zhang H, et al
    BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


    August 2017
  230. HUDDY JR, Huddy FMS, Markar SR, Tucker O, et al
    Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer - A narrative review.
    Dis Esophagus. 2017 Aug 30. doi: 10.1093.
    PubMed     Abstract available


  231. YAP WK, Chang YC, Tseng CK, Hsieh CH, et al
    Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Abstract available


  232. NAKATANI M, Migita K, Matsumoto S, Wakatsuki K, et al
    Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  233. GANNON JA, Guinan EM, Doyle SL, Beddy P, et al
    Reduced fitness and physical functioning are long-term sequelae after curative treatment for esophageal cancer: a matched control study.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


    July 2017
  234. SANFORD NN, Catalano PJ, Enzinger PC, King BL, et al
    A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  235. CHEN Y, Hao D, Wu X, Xing W, et al
    Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  236. HAISLEY KR, Hart KD, Nabavizadeh N, Bensch KG, et al
    Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


    June 2017
  237. QIAN X, Tan C, Yang B, Wang F, et al
    Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  238. SUN L, Cao J, Guo C, Burnett J, et al
    Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  239. UNO K, Koike T, Kusaka G, Takahashi Y, et al
    Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  240. KAWAI R, Abe T, Uemura N, Fukaya M, et al
    Feeding catheter gastrostomy with the round ligament of the liver prevents mechanical bowel obstruction after esophagectomy.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  241. DOYLE SL, Mongan AM, Donohoe CL, Pidgeon GP, et al
    Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma.
    Dis Esophagus. 2017;30:1-11.
    PubMed     Abstract available


  242. MATSUEDA K, Manabe N, Toshikuni N, Sato Y, et al
    Clinical characteristics and associated factors of Japanese patients with adenocarcinoma of the esophagogastric junction: a multicenter clinicoepidemiological study.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


  243. LI SJ, Wang ZQ, Li YJ, Fan J, et al
    Diabetes mellitus and risk of anastomotic leakage after esophagectomy: a systematic review and meta-analysis.
    Dis Esophagus. 2017;30:1-12.
    PubMed     Abstract available


    May 2017
  244. HE Y, Liu J, Zhao Z, Zhao H, et al
    Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  245. CHEN HL, Shen WQ, Liu K
    Radioactive self-expanding stents for palliative management of unresectable esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017;30:1-16.
    PubMed     Abstract available


  246. AKIYAMA Y, Iwaya T, Endo F, Shioi Y, et al
    Stability of cervical esophagogastrostomy via hand-sewn anastomosis after esophagectomy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  247. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor-Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  248. WIGHTMAN SC, Posner MC, Patti MG, Ganai S, et al
    Extremes of body mass index and postoperative complications after esophagectomy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


    April 2017
  249. ZHANG Z, Zhang H
    Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  250. LACERDA CF, Cruvinel-Carloni A, de Oliveira AT, Scapulatempo-Neto C, et al
    Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Abstract available


  251. DE B, Rhome R, Doucette J, Buckstein M, et al
    Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Abstract available


  252. VAN RULER MA, Peters FP, Slingerland M, Fiocco M, et al
    Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Abstract available


  253. RATNASINGHAM K, Stroud L, Knight J, Preston SR, et al
    Analysis of 11 years of clinical negligence claims in esophagogastric cancer in England.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  254. DUAN J, Deng T, Ying G, Zhang H, et al
    Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  255. POWELL AG, Hughes DL, Brown J, Larsen M, et al
    Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  256. GIACOPUZZI S, Weindelmayer J, Treppiedi E, Bencivenga M, et al
    Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


    March 2017
  257. MA M, Shroff S, Feldman M, DeMarshall M, et al
    Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  258. KOJIMA K, Yamashita K, Ushiku H, Katoh H, et al
    The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Abstract available


    February 2017
  259. MARSHALL-WEBB M, Bright T, Price T, Thompson SK, et al
    Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  260. WEINER JP, Shao M, Schwartz D, Wong A, et al
    Patterns of care and survival outcomes in the treatment of esophageal melanoma.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


  261. WONG AT, Shao M, Rineer J, Osborn V, et al
    Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  262. YANG H, Feng C, Cai BN, Yang J, et al
    Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  263. MURPHY CC, Yang YC, Shaheen NJ, Hofstetter WL, et al
    An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  264. MALIK V, Johnston C, O'Toole D, Lucey J, et al
    Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  265. ROSMOLEN WD, Nieuwkerk PT, Pouw RE, van Berge Henegouwen MI, et al
    Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Abstract available


  266. LINDNER K, Lubbe L, Muller AK, Palmes D, et al
    Potential risk factors and outcomes of fistulas between the upper intestinal tract and the airway following Ivor-Lewis esophagectomy.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  267. KJAER DW, Nassar M, Jensen LS, Svendsen LB, et al
    A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  268. MANNER H, Wetzka J, May A, Pauthner M, et al
    Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Dis Esophagus. 2017;30:1-11.
    PubMed     Abstract available


  269. CHEN H, Ni Z, Jing D, He L, et al
    Novel stent in the palliation of malignant esophageal strictures: a retrospective study.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  270. OJIMA T, Nakamori M, Nakamura M, Katsuda M, et al
    Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


    January 2017
  271. MATSUMOTO A, Watanabe M, Mine S, Nishida K, et al
    Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


  272. LINDER G, Hedberg J, Bjorck M, Sundbom M, et al
    Perfusion of the gastric conduit during esophagectomy.
    Dis Esophagus. 2017;30:143-149.
    PubMed     Abstract available


  273. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  274. DEPYPERE L, Lerut T, Moons J, Coosemans W, et al
    Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  275. JANUSZEWICZ W, Kaminski MF, Wieszczy P, Wronska E, et al
    Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


  276. GOENSE L, van Rossum PS, Tromp M, Joore HC, et al
    Intraoperative and postoperative risk factors for anastomotic leakage and pneumonia after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Abstract available


  277. SALEM AI, Thau MR, Strom TJ, Abbott AM, et al
    Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  278. WU HL, Guan BX, Liu B, Wang HJ, et al
    The intrapapillary capillary loop (IPCL) changes in superficial esophageal lesions.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  279. HAVERKAMP L, Seesing MF, Ruurda JP, Boone J, et al
    Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  280. PANTHAM G, Ganesan S, Einstadter D, Jin G, et al
    Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  281. ZHAO J, Han Y, Lei J, Zhou Y, et al
    Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  282. VAN ROSSUM PS, Haverkamp L, Carvello M, Ruurda JP, et al
    Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  283. VAN EGMOND MA, van der Schaaf M, Klinkenbijl JH, Engelbert RH, et al
    Preoperative functional status is not associated with postoperative surgical complications in low risk patients undergoing esophagectomy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Abstract available


  284. PARK A, Lee JH, Park A, Jung YH, et al
    Prevalence rate and clinical characteristics of esophageal ectopic sebaceous glands in asymptomatic health screen examinees.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Abstract available


  285. D'JOURNO XB, Berbis J, Jougon J, Brichon PY, et al
    External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Abstract available


  286. FUCHS HF, Harnsberger CR, Broderick RC, Chang DC, et al
    Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Abstract available


    November 2016
  287. NIE L, Wu HY, Shen YH, Fan XS, et al
    Esophageal submucosal gland duct adenoma: a clinicopathological and immunohistochemical study with a review of the literature.
    Dis Esophagus. 2016;29:1048-1053.
    PubMed     Abstract available


  288. ZHANG Z, Ai B, Liao Y, Liu L, et al
    Novel methylene blue staining technique for localizing small esophageal leiomyomas during thoracoscopic enucleation.
    Dis Esophagus. 2016;29:1043-1047.
    PubMed     Abstract available


  289. STIEKEMA J, Cats A, Boot H, Langers AM, et al
    Biobanking of fresh-frozen endoscopic biopsy specimens from esophageal adenocarcinoma.
    Dis Esophagus. 2016;29:1100-1106.
    PubMed     Abstract available


  290. NOSHIRO H, Yoda Y, Hiraki M, Kono H, et al
    Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy.
    Dis Esophagus. 2016;29:1090-1099.
    PubMed     Abstract available


  291. ACAR T, Savas R, Kocacelebi K, Ersoz G, et al
    Squamous cell carcinoma arising from a Zenker's diverticulum: contribution of FDG-PET/CT to the diagnosis.
    Dis Esophagus. 2016;29:1170-1171.
    PubMed    


  292. SCARPA M, Cavallin F, Saadeh LM, Pinto E, et al
    Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status.
    Dis Esophagus. 2016;29:1064-1070.
    PubMed     Abstract available


  293. ZHAO X, Wang X, Li A, Sheng J, et al
    Endoscopic resection of a giant esophageal lipoma: a case report.
    Dis Esophagus. 2016;29:1167-1169.
    PubMed    


  294. NAGAI K, Tsujii Y, Matsui T, Yoshii S, et al
    Esophagogastric junctional adenocarcinoma originating from endoscopically unrecognizable Barrett's epithelium.
    Dis Esophagus. 2016;29:1164-1166.
    PubMed    


  295. RICE TW, Ishwaran H, Hofstetter WL, Kelsen DP, et al
    Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:897-905.
    PubMed     Abstract available


  296. RICE TW, Ishwaran H, Blackstone EH, Hofstetter WL, et al
    Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:913-919.
    PubMed     Abstract available


  297. RICE TW, Ishwaran H, Kelsen DP, Hofstetter WL, et al
    Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:906-912.
    PubMed     Abstract available


  298. SHAH IA, Bhat GA, Mehta P, Lone MM, et al
    Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.
    Dis Esophagus. 2016;29:937-943.
    PubMed     Abstract available


  299. ZHAN C, Yan L, Wang L, Jiang W, et al
    Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Dis Esophagus. 2016;29:920-928.
    PubMed     Abstract available


    August 2016
  300. NIWA Y, Koike M, Fujimoto Y, Oya H, et al
    Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
    Dis Esophagus. 2016;29:598-602.
    PubMed     Abstract available


  301. KUNZLI HT, van Berge Henegouwen M, Gisbertz S, Seldenrijk C, et al
    Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study.
    Dis Esophagus. 2016;29:649-55.
    PubMed     Abstract available


  302. TSOU YK, Chuang WY, Liu CY, Ohata K, et al
    Learning curve for endoscopic submucosal dissection of esophageal neoplasms.
    Dis Esophagus. 2016;29:544-50.
    PubMed     Abstract available


  303. NABAVIZADEH N, Shukla R, Elliott DA, Mitin T, et al
    Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
    Dis Esophagus. 2016;29:614-20.
    PubMed     Abstract available


  304. BRANKLEY SM, Halling KC, Jenkins SM, Timmer MR, et al
    Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.
    Dis Esophagus. 2016;29:513-9.
    PubMed     Abstract available


  305. OYA H, Kanda M, Koike M, Iwata N, et al
    Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2016;29:663-9.
    PubMed     Abstract available


  306. SWAGER A, Boerwinkel DF, de Bruin DM, Weusten BL, et al
    Volumetric laser endomicroscopy in Barrett's esophagus: a feasibility study on histological correlation.
    Dis Esophagus. 2016;29:505-12.
    PubMed     Abstract available


  307. CONG QX, Zhang H, Sun SX, Li HF, et al
    Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.
    Dis Esophagus. 2016;29:621-6.
    PubMed     Abstract available


  308. MINEGAKI T, Fukushima S, Morioka C, Takanashi H, et al
    Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
    Dis Esophagus. 2016;29:656-62.
    PubMed     Abstract available


  309. SCARPA M, Filip B, Cavallin F, Alfieri R, et al
    Esophagectomy in elderly patients: which is the best prognostic score?
    Dis Esophagus. 2016;29:589-97.
    PubMed     Abstract available


  310. DAY RW, Jaroszewski D, Chang YH, Ross HJ, et al
    Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
    Dis Esophagus. 2016;29:583-8.
    PubMed     Abstract available


    July 2016
  311. HAVERKAMP L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, et al
    Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands.
    Dis Esophagus. 2016;29:435-41.
    PubMed     Abstract available


  312. SUNDE B, Ericson J, Kumagai K, Lundell L, et al
    Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Dis Esophagus. 2016;29:442-7.
    PubMed     Abstract available


  313. WANG BJ, Zhang B, Yan SS, Li ZC, et al
    Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis.
    Dis Esophagus. 2016;29:448-54.
    PubMed     Abstract available


  314. MORI K, Yamagata Y, Aikou S, Nishida M, et al
    Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.
    Dis Esophagus. 2016;29:429-34.
    PubMed     Abstract available


  315. WAN J, Wu W, Che Y, Kang N, et al
    Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
    Dis Esophagus. 2016;29:412-20.
    PubMed     Abstract available


  316. LI B, Tang SP, Wang KZ
    Esophagus cancer and occupational exposure to asbestos: results from a meta-analysis of epidemiology studies.
    Dis Esophagus. 2016;29:421-8.
    PubMed     Abstract available


  317. JI WH, Jiang YH, Ji YL, Li B, et al
    Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Dis Esophagus. 2016;29:403-11.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: